Research report
Hillman Capital Management Q1 2026 13F Holdings and Activit…
Verified Q1 2026 13F holdings for Hillman Capital Management, covering institutional activity, data dates, SEC sources, filing limits, and methods.
Hillman Capital Management
Mark Hillman
Period
Q2 2026
Portfolio Date
Jun 30, 2026
Stocks Held
54
Market Value
$138.2M
Holdings Value Trend
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Top 5 Holdings
$CVS
CVS Health Corporation
4.2%
% of Portfolio
$BIIB
Biogen Inc.
3.8%
% of Portfolio
$DD
DuPont de Nemours, Inc.
3.7%
% of Portfolio
$WBD
Warner Bros. Discovery, Inc.
3.7%
% of Portfolio
$BAX
Baxter International Inc.
3.6%
% of Portfolio
Historical Positions
| Symbol | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| CVS | 4.2% | 3.4% | 3.6% | 3.6% |
| BIIB | 3.8% | 3.8% | 3.4% | - |
| DD | 3.7% | 3.8% | 3.4% | 3.2% |
| WBD | 3.7% | 3.7% | 3.9% | 3.8% |
| BAX | 3.6% | - | - | - |
| IFF | 3.6% | 3.7% | 3.2% | - |
| GSK | 3.5% | 3.7% | 3.5% | 3.6% |
| KMX | 3.5% | 3.1% | - | - |
| BA | 3.4% | - | 3.5% | 3.6% |
| ZBH | 3.4% | 3.5% | - | - |
Post-Filing Contributors
Price change since reported price, ranked by portfolio contribution
Post-Filing Detractors
Price change since reported price, ranked by portfolio contribution
Sector Analysis
Trading Summary
All Holdings
$CVS
4.2%
$BIIB
3.8%
$DD
3.7%
$WBD
3.7%
$BAX
3.6%
$IFF
3.6%
$GSK
3.5%
$KMX
3.5%
$BA
3.4%
$ZBH
3.4%
$KHC
3.4%
$BF.B
3.3%
$PFE
3.0%
$EL
2.9%
$FI
2.8%
$MSFT
2.8%
$CPB
2.6%
$ADBE
2.6%
$ETF-EFA
2.4%
$NKE
2.3%
$TSM
1.9%
$BMY
1.9%
$WST
1.9%
$USB
1.8%
$VEEV
1.8%
$CMCSA
1.8%
$DIS
1.8%
$CAG
1.8%
$VZ
1.8%
$UPS
1.7%
$BDX
1.7%
$UNH
1.6%
$DEO
1.6%
$STZ
1.6%
$CRM
1.6%
$EFX
1.4%
$AKAM
1.4%
$HSY
1.4%
$ORCL
1.2%
$ETF-IVV
0.9%
$MDT
0.3%
$TROW
0.3%
$APD
0.3%
$ACN
0.3%
$TMO
0.3%
$RTX
0.3%
$GOOG
0.3%
$NOW
0.3%
$CLX
0.2%
$BLK
0.2%